Advertisement Cytheris reports promising results from Phase I/II HIV trial - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Cytheris reports promising results from Phase I/II HIV trial

Cytheris has reported positive results of the long-term follow-up of patients in a multi-center Phase I/II study of Interleukin-7/IL-7 therapy in chronically HIV-1 infected patients, whose CD4+ T-cell counts remained low despite treatment with anti-retroviral-therapies or HAART.

Non-GAAP adjusted earnings from continuing operation per ADS increased by about 80% year-over-year to about RMB15.8 for fiscal 2008.

For the fourth quarter of fiscal 2008, Revenues from continuing operation increased by about 37% year-over-year to about RMB248 million. Non-GAAP adjusted income from continuing operation increased by about 43% year-over-year to about RMB116 million. Non-GAAP adjusted earnings from continuing operation per ADS increased by about 44% year-over-year to about RMB4.4.

China Medical is a China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products.